ANEW Medical Price to Free Cash Flow Ratio 2023-2024 | KLTO
Historical price to free cash flow ratio values for ANEW Medical (KLTO) since 2023.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
ANEW Medical Price to Free Cash Flow Ratio Historical Data |
Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
2024-09-18 |
0.89 |
|
inf |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.015B |
$0.000B |
ANEW MEDICAL INC. specializes in the development of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. The company's focus on central nervous systems diseases utilizing cell and gene therapies to mitigate age-related pathologies such as Alzheimer's disease, dementia symptoms and neuromuscular diseases. ANEW MEDICAL INC., formerly known as REDWOODS ACQ, is based in NEW YORK.
|